Scroll
Our Science
World-leading capabilities in multiplexable gene editing
Genome editing for immune-privileged features
Newsroom
Press Releases
Qihan Biotech Announces Appointment of Carl June to Scientific Advisory Board
2024/12/19
Qihan Biotech is proud to announce the appointment of Dr. Carl June as Cell Therapy Chair of its Scientific Advisory Board.
1 / 3
Press Releases
Qihan Biotech Announces NMPA Approval of Investigational New Drug (IND) Application for QN-019a, a Multi-locus Gene-Editing Cell Therapy Product to treat CD19-positive B-Cell Lymphoma
2023/07/17
Qihan Biotech announced today that the National Medical Products Administration (NMPA) approved its clinical trial application for the product QN-019a.
1 / 3
Press Releases
Qihan Biotech Appoints Tony W. Ho to its Board of Directors
2022/10/16
Qihan Biotech today announced the appointment of Tony W. Ho, M.D., to its Board of Directors as an independent director.
1 / 3
Join Our Team
Contact Us
Hangzhou Qihan Biotech Co., Ltd.
Address: Xiaoshan District, Hangzhou, Zhejiang, China
Zipcode: 311200
TEL: 0571-83500380
FAX: 0571-83500370